Funding Opportunities Related To COVID-19

Last updated on July 19, 2021

The OSR, Office of Clinical Trial Activation (OCTA), and Contracts and Grants Accounting (CGA) are working to ensure continuity of services for researchers, as well as prioritizing COVID-19 research and clinical trials.

Go to our COVID-19 page for sponsor specific guidance, the impact of research and additional resources. 

Please notify your RSC of any intention to submit a proposal ASAP.

NIH - National Institutes of Health

  • Funding Opportunities Specific to COVID-19 are posted on the UCSF Office of Research COVID-19 central clearinghouse. Scroll down and click on Funding. 
  • OD - NOT-OD-20-118 Guide Notice of Information Highlighting Harmonization and Data Sharing Expectations for Supplement and Revision Projects Addressing Social, Behavioral, Economic and Health Impacts of the COVID-19 Public Health Emergency
    • Related NOSIs: NOT-MD-20-019, NOT-AG-20-022, NOT-ES-20-020, NOT-AA-20-011, NOT-HG-20-030, NOT-MH-20-047
  • NCI - NOT-CA-20-054 Contributing to the Global COVID-19 Crisis Response by Allowing Some NCI-supported Projects to be redirected to COVID-19-Related Research During the Crisis
  • NIBIB - NIH POCTRN - Fast-Track Program for COVID-19 Test Development and Distribution Innovative Technologies to Increase U.S. Capacity for COVID-19 Testing Rolling Submission from April 29, 2020 until further ntoice.

  TOP

COVID-19 Supplements and Funded Extensions for Existing Awards:

NOSIs for COVID competing and administrative revisions to existing awards (using PA-20-135, PA-18-935, PA-20-272) will be listed below until expired.

NIH
IC

 COVID
NOSI

Compet.

PA-20-
135 expands scope

Compet. 

PA-18-
935
expands scope

Admin. 

PA-20-272 
within scope

 Noted
Requireiments
(See NOSI)		 Deadline Release Expires

NICHD

NOT-HD-21-037

   X X

Submit applications with single-project application
form package

Investigators are advised
to contact the parent
award program officers
before applying.

9/7/21

1/7/22

5/7/22

 7/2/21 5/8/22

NIDA

NOT-DA-
21-046

     X

Eligible applicants must be
 NIDA F30, F31, F32,
K99, K01, K08, K23, or K25 awardees whose grant is in its final year

 Rolling basis through 5/31/21 5/19/21  

NIAID

NOT-AI-
21-052

     X

Applicants are strongly encouraged to consult with the assigned
Program Official for the parent award and/or the Office of Research Training and Special Programs via email at 

[email protected]
prior to submission.

 6/7/21 5/6/21  

NIAID

NOT-AI-
21-051

     X

Applicants are strongly encouraged to consult with the assigned
Program Official for the parent award and/or the Office of Research Training and Special Programs via email at 

[email protected]
prior to submission.

  6/7/21  5/6/21  

NIDA

NOT-DA-
21-041

 X   X All applications, even multi-components,
must be submitted using the
Single Component form package

Rolling basis through 3/31/22

 4/15/21 3/31/22

NIDA

NOT-DA-
21-032

     X  

Rolling basis 4/1/21 through 3/31/22

 3/25/21 4/1/22
NCATS NOT-TR-
20-017		 X    

Only existing UG3/UH3, R43/R44, R41/R42, R01, U01 NCATS/NIH Microphysiological Systems

FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will expire June 25

 Rolling basis from 5/15/20-1/25/22 4/9/20 1/26/22
NCATS NOT-TR-
21-017		     X

Supplements PAR-18-940, PAR-18-464,
PAR-15-304, RFA-TR-14-009, RFA-TR-17-006,
RFA-TR-16-021, RFA-TR-15-002 and RFA-TR-15-004

 Rolling basis 1/28/21- 8/16/24 2/3/21 8/17/24

NIGMS

NOT-GM-21-019

   X     Rolling basis from 3/15/21 - 12/15/21 2/25/21 12/16/21

 

 

 Go to our COVID-19 page for sponsor specific guidance, the impact of research and additional resources.